Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $900.24 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $191.36 | 12 | $0 (2023) |
| DePuy Synthes Sales Inc. | $124.33 | 1 | $0 (2020) |
| PFIZER INC. | $97.61 | 6 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $70.54 | 5 | $0 (2019) |
| Amgen Inc. | $69.59 | 5 | $0 (2022) |
| AbbVie Inc. | $64.36 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $60.77 | 5 | $0 (2019) |
| Novo Nordisk Inc | $46.38 | 3 | $0 (2022) |
| Baxter Healthcare | $42.86 | 2 | $0 (2022) |
| Abbott Laboratories | $41.84 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.50 | 1 | Dexcom, Inc. ($17.50) |
| 2023 | $69.55 | 4 | Novartis Pharmaceuticals Corporation ($36.49) |
| 2022 | $308.31 | 19 | Novartis Pharmaceuticals Corporation ($78.54) |
| 2021 | $18.70 | 1 | AbbVie Inc. ($18.70) |
| 2020 | $136.03 | 2 | DePuy Synthes Sales Inc. ($124.33) |
| 2019 | $63.11 | 4 | PFIZER INC. ($20.08) |
| 2018 | $142.62 | 10 | PFIZER INC. ($50.82) |
| 2017 | $144.42 | 10 | Novartis Pharmaceuticals Corporation ($60.59) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Endocrinology | ||||||
| 09/27/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Bone Health | ||||||
| 10/06/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Obesity | ||||||
| 09/21/2022 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 09/21/2022 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 09/21/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.61 | General |
| 09/14/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Bone Health | ||||||
| 08/03/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/20/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 06/14/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/09/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular | ||||||
| 06/01/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Bone Health | ||||||
| 05/25/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/27/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Inflammation | ||||||
| 04/26/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiology | ||||||
| 03/24/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes Care | ||||||
| 03/23/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/09/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/17/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Diabetes Care | ||||||
| 12/16/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 133 | 224 | $35,078 | $18,943 |
| 2022 | 5 | 204 | 358 | $49,624 | $26,232 |
| 2021 | 6 | 339 | 615 | $67,652 | $36,897 |
| 2020 | 12 | 488 | 721 | $73,823 | $28,457 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 161 | $22,795 | $12,202 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $11,261 | $6,275 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,022 | $466.31 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 249 | $36,272 | $18,666 | 51.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $8,432 | $4,120 | 48.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 26 | 26 | $2,652 | $1,827 | 68.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $1,486 | $851.97 | 57.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 34 | $782.00 | $767.28 | 98.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 361 | $50,179 | $28,602 | 57.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $10,620 | $5,596 | 52.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 18 | $1,746 | $952.57 | 54.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 39 | 39 | $1,950 | $800.67 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $897.00 | $609.57 | 68.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 82 | 113 | $2,260 | $336.60 | 14.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 357 | $48,469 | $22,418 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 19 | 19 | $3,510 | $2,081 | 59.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 19 | $1,690 | $740.15 | 43.8% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 22 | 24 | $979.00 | $655.38 | 66.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 49 | 49 | $4,851 | $642.88 | 13.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2020 | 53 | 54 | $7,452 | $558.90 | 7.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 53 | 55 | $2,145 | $418.55 | 19.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 20 | $488.00 | $309.14 | 63.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 27 | 27 | $1,836 | $257.04 | 14.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 57 | 60 | $690.00 | $176.40 | 25.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2020 | 19 | 19 | $1,083 | $107.54 | 9.9% |
About Dr. John Shank, MD
Dr. John Shank, MD is a Family Medicine healthcare provider based in Summersville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306835152.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shank, MD has received a total of $900.24 in payments from pharmaceutical and medical device companies, with $17.50 received in 2024. These payments were reported across 51 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($900.24).
As a Medicare-enrolled provider, Shank has provided services to 1,164 Medicare beneficiaries, totaling 1,918 services with total Medicare billing of $110,528. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Summersville, WV
- Active Since 10/14/2005
- Last Updated 04/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306835152
Products in Payments
- ENTRESTO (Drug) $173.34
- ELIQUIS (Drug) $126.69
- VA-LCP PLATES & SCREWS (Device) $124.33
- LINZESS (Drug) $49.40
- XARELTO (Drug) $47.56
- EVENITY (Biological) $44.78
- FREESTYLE LIBRE 2 (Device) $41.84
- CHANTIX (Drug) $29.76
- ZOSTAVAX (Biological) $28.63
- LEQVIO (Drug) $18.02
- Dexcom G6 Transmitter (Medical Supply) $17.50
- Saxenda (Drug) $17.41
- Vascepa (Drug) $16.50
- VIBERZI (Drug) $14.96
- SHINGRIX (Biological) $14.67
- XIFAXAN (Drug) $13.30
- INVOKANA (Drug) $13.21
- Otezla (Drug) $12.41
- Repatha (Biological) $12.40
- LYRICA (Drug) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Summersville
Dr. Michael Taylor, Md, MD
Family Medicine — Payments: $4,578
Dr. Richard Trenbath, M.d, M.D
Family Medicine — Payments: $2,276
Kathy Hamon, Do, DO
Family Medicine — Payments: $1,896
Bruce Greenberg, Md, MD
Family Medicine — Payments: $1,833
Mark Wantz, Md, MD
Family Medicine — Payments: $1,496
Margaret Wantz, Md, MD
Family Medicine — Payments: $1,115